ExodusPoint Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-46,927
Closed -$1.26M 2048
2025
Q3
$1.26M Buy
+46,927
New +$1.12M 0.01% 875
2024
Q4
Sell
-240,740
Closed -$8.94M 2028
2024
Q3
$8.94M Buy
+240,740
New +$8.98M 0.05% 256
2023
Q1
Sell
-53,973
Closed -$2.62M 2105
2022
Q4
$2.62M Buy
53,973
+42,325
+363% +$2.65M 0.04% 541
2022
Q3
$822K Sell
11,648
-10,395
-47% -$890K 0.01% 1188
2022
Q2
$1.56M Buy
+22,043
New +$1.42M 0.02% 892
2022
Q1
Sell
-32,416
Closed -$2.96M 2651
2021
Q4
$2.96M Buy
32,416
+23,824
+277% +$2.56M 0.03% 607
2021
Q3
$1.1M Buy
+8,592
New +$1.2M 0.01% 981
2020
Q3
Sell
-12,627
Closed -$777K 2207
2020
Q2
$777K Sell
12,627
-15,463
-55% -$632K 0.02% 866
2020
Q1
$906K Sell
28,090
-47,622
-63% -$1.6M 0.05% 327
2019
Q4
$2.66M Buy
75,712
+66,320
+706% +$2.19M 0.05% 277
2019
Q3
$242K Sell
9,392
-74
-0.8% -$2.25K 0.01% 1015
2019
Q2
$278K Buy
+9,466
New +$273K 0.01% 741

Other funds holding STAA

ExodusPoint Capital Management's STAA Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 46,927 shares — an estimated $1.26M sold.

ExodusPoint Capital Management first reported a position in STAA in Q2 2019 and held it in 12 quarters. The position peaked at $8.94M in Q3 2024. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

  • ExodusPoint Capital Management reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 46,927 STAAR Surgical shares in Q4 2025, an estimated $1.26M.
  • ExodusPoint Capital Management first reported a position in STAAR Surgical in Q2 2019 and held it in 12 quarters.
  • ExodusPoint Capital Management's STAAR Surgical position peaked at $8.94M in Q3 2024.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.